npj women's healthPub Date : 2025-01-01Epub Date: 2025-02-22DOI: 10.1038/s44294-025-00060-4
Céline Constantin, Daria Matvienko, Csaba László, Valentina Scabia, Laura Battista, Pierre-Alain Binz, Stephen J Bruce, Cathrin Brisken
{"title":"Mimicking women's endocrine milieu in mice for women's health-related studies.","authors":"Céline Constantin, Daria Matvienko, Csaba László, Valentina Scabia, Laura Battista, Pierre-Alain Binz, Stephen J Bruce, Cathrin Brisken","doi":"10.1038/s44294-025-00060-4","DOIUrl":"10.1038/s44294-025-00060-4","url":null,"abstract":"<p><p>To improve preclinical studies and their translation, patient-derived xenografts (PDXs) are increasingly used. They have human-specific tumor characteristics and reflect intra and inter-tumor heterogeneity. However, the endocrine milieu differs between humans and host mice. In light of sex-specific cancer biology and a rise in endocrine-related cancers there is an urgent need to correctly reflect the hormonal milieu in PDX models. We show that female mice of <i>NOD.Cg-Prkdc</i> <sup><i>scid</i></sup> <i>Il2rg</i> <sup><i>tm1Wjl</i></sup> <i>/SzJ (NSG)</i> strain widely used for PDXs has 17-β-estradiol (E2) and testosterone (T) levels comparable to <i>C57Bl6</i> females but higher progesterone (P4) levels. E2 levels are comparable, T levels are lower and P4 levels higher than those observed in postmenopausal women. Ovariectomy increases T to levels observed in postmenopausal women. Subcutaneous E2 and combined E2/P4 silicon pellets provide <i>NSG</i> females with premenopausal ovarian hormone levels. These procedures humanize the endocrine environment of experimental animals, improving PDX relevance in women's health-related research.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143485476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-06-13DOI: 10.1038/s44294-025-00085-9
Chee Wai Ku, Yu Bin Tan, Kuan Yang Chew, Chee Onn Ku, Shi Tong Carissa Ng, Thiam Chye Tan, Yie Hou Lee
{"title":"Untargeted metabolomics reveals key pathways in miscarriage: steroid, folate, fatty acid & glycosaminoglycan metabolism.","authors":"Chee Wai Ku, Yu Bin Tan, Kuan Yang Chew, Chee Onn Ku, Shi Tong Carissa Ng, Thiam Chye Tan, Yie Hou Lee","doi":"10.1038/s44294-025-00085-9","DOIUrl":"10.1038/s44294-025-00085-9","url":null,"abstract":"<p><p>Metabolites influencing miscarriage outcomes remain understudied. We hypothesized that aberrant metabolism impacts threatened miscarriage outcomes and that understanding these pathways could offer new management strategies. This case-control study analyzed serum metabolomics from 80 women between 5 and 12 weeks' gestation at KK Women's and Children's Hospital, Singapore, comparing three groups: women with threatened miscarriage who miscarried (TM<sub>MC</sub>), those with ongoing pregnancies (TM<sub>O</sub>), and women with normal pregnancies (NP). Using untargeted liquid chromatography-mass spectrometry and pathway analysis through MetaboAnalyst 5.0 and the Kyoto Encyclopedia of Genes and Genomes, 267 metabolites across 12 enriched pathways were identified. Dysregulations in steroid (AUC 0.82), folate (AUC 0.59), fatty acid (AUC 0.70), and glucosaminoglycan (AUC 0.64) pathways distinguished women who miscarried from those with ongoing pregnancies (TM<sub>MC</sub> vs TM<sub>O</sub>). We provide initial insights into the metabolic profile associated with miscarriage, highlighting disruptions in steroid hormone, fatty acid, folate, and glucosaminoglycan biosynthesis. Further validation may support biomarker development for prognostication.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-02-06DOI: 10.1038/s44294-024-00052-w
Camran R Nezhat, Tomiko T Oskotsky, Joshua F Robinson, Susan J Fisher, Angie Tsuei, Binya Liu, Juan C Irwin, Brice Gaudilliere, Marina Sirota, David K Stevenson, Linda C Giudice
{"title":"Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence.","authors":"Camran R Nezhat, Tomiko T Oskotsky, Joshua F Robinson, Susan J Fisher, Angie Tsuei, Binya Liu, Juan C Irwin, Brice Gaudilliere, Marina Sirota, David K Stevenson, Linda C Giudice","doi":"10.1038/s44294-024-00052-w","DOIUrl":"10.1038/s44294-024-00052-w","url":null,"abstract":"<p><p>Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgical metadata can identify multiple disease subtypes with translation to novel diagnostics and therapeutics. Herein, we present real-world perspectives on endometriosis and the importance of multidisciplinary collaboration in informing molecular, epidemiologic, and cell-specific data in the clinical and surgical contexts.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11802455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-05-05DOI: 10.1038/s44294-025-00076-w
Ian M Greenlund, Jill N Barnes, Sarah E Baker, Virend K Somers, Joshua M Bock
{"title":"Sex differences in sleep apnea and Alzheimer's Disease: role of cerebrovascular dysfunction.","authors":"Ian M Greenlund, Jill N Barnes, Sarah E Baker, Virend K Somers, Joshua M Bock","doi":"10.1038/s44294-025-00076-w","DOIUrl":"https://doi.org/10.1038/s44294-025-00076-w","url":null,"abstract":"<p><p>Obstructive sleep apnea (OSA) significantly impacts cardiovascular health in post-menopausal females. Given that cardiovascular and cerebrovascular diseases are tightly linked, OSA-mediated impacts on cerebrovascular function and Alzheimer's Disease (AD) risk are also likely more manifest in females. This review will: summarize sex differences in cerebrovascular function, review the vascular hypothesis of AD, characterize sex differences in the OSA phenotype and implications for cerebrovascular control, and highlight OSA-mediated AD risk.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144016106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-01-03DOI: 10.1038/s44294-024-00049-5
Zhexian Sun, Wenjie Wu, Zezhen Xiang, Hansong Gao, Weina Ju, Cherilyn Uhm, Ian S Hagemann, Pamela K Woodard, Nanbert Zhong, Alison G Cahill, Qing Wang, Yong Wang
{"title":"Quantitative and longitudinal assessment of human placental inflammation using diffusion basis spectrum imaging.","authors":"Zhexian Sun, Wenjie Wu, Zezhen Xiang, Hansong Gao, Weina Ju, Cherilyn Uhm, Ian S Hagemann, Pamela K Woodard, Nanbert Zhong, Alison G Cahill, Qing Wang, Yong Wang","doi":"10.1038/s44294-024-00049-5","DOIUrl":"https://doi.org/10.1038/s44294-024-00049-5","url":null,"abstract":"<p><p>Besides exchanging nutrients, gases, and wastes, placenta is an intermediary between maternal and fetal immune systems. However, no method exists to safely image and monitor placental inflammation during pregnancy. We customized a Magnetic Resonance Imaging (MRI) method, diffusion basis spectrum imaging (DBSI), to measure immune cells in placenta. We validated placental DBSI in simulations and ex-vivo specimens, then applied it to 202 MRI scans from 82 patients whose placentas were classified as non-inflammation (<i>n</i> = 70) or inflammation (<i>n</i> = 12). Our method imaged the 3D distribution of immune cells, revealing significantly greater infiltration in the inflammation placentas from early (2.8% ± 0.7% vs. 4.8% ± 0.65%, <i>p</i> < 0.01) to late pregnancy (4.75% ± 0.9% vs. 7.25% ± 2.13%, <i>p</i> < 0.01). DBSI detects elevated immune cell infiltration associated with placental inflammation and enables non-invasive imaging of placental inflammation, offering early detection and monitoring throughout pregnancy, facilitating personalized care and potentially improving pregnancy outcomes without ionizing radiation.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-02-25DOI: 10.1038/s44294-025-00063-1
Aysegul Atasoy-Zeybek, Kelly K Showel, Christopher V Nagelli, Jennifer J Westendorf, Christopher H Evans
{"title":"The intersection of aging and estrogen in osteoarthritis.","authors":"Aysegul Atasoy-Zeybek, Kelly K Showel, Christopher V Nagelli, Jennifer J Westendorf, Christopher H Evans","doi":"10.1038/s44294-025-00063-1","DOIUrl":"10.1038/s44294-025-00063-1","url":null,"abstract":"<p><p>Osteoarthritis (OA) is a chronic joint disease characterized by cartilage degradation, inflammation, and pain. While multiple factors contribute to OA development, age and sex are primary risk factors, particularly affecting postmenopausal women. The dramatic increase in OA risk after menopause suggests estrogen deficiency accelerates disease progression. This review explores the molecular mechanisms connecting aging and estrogen deficiency in OA development, focusing on key genes and pathways identified through RNA sequencing.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11860234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-04-25DOI: 10.1038/s44294-025-00072-0
Roma Dhingra, Kosuke Tamura, Jinani Jayasekera, Amina P Alio, Allana T Forde
{"title":"A systematic review of the relationship between neighborhood stressors, discrimination, and cardiometabolic outcomes during pregnancy.","authors":"Roma Dhingra, Kosuke Tamura, Jinani Jayasekera, Amina P Alio, Allana T Forde","doi":"10.1038/s44294-025-00072-0","DOIUrl":"https://doi.org/10.1038/s44294-025-00072-0","url":null,"abstract":"<p><p>Cardiometabolic outcomes during pregnancy, including hypertensive disorders of pregnancy (HDP) and gestational diabetes, disproportionately affect racial and/or ethnic minority groups in the United States. These disparities are not fully explained by traditional risk factors, but race-related psychosocial stressors such as perceived neighborhood stressors and discrimination (PNSD) may contribute to adverse health outcomes. This systematic review examined the literature on the impact of PNSD on HDP and gestational diabetes. A comprehensive search of PubMed, PsycINFO, Embase, Web of Science, and CINAHL identified 10 eligible studies: seven cohort and three cross-sectional studies. Five studies reported significant associations between PNSD and increased risk for cardiometabolic outcomes during pregnancy (HDP-1 study, gestational diabetes-3 studies, both hypertension and diabetes during pregnancy-1 study). The included studies demonstrated good methodological quality. These findings suggest that PNSD may be associated with cardiometabolic outcomes during pregnancy, but further research is needed, particularly on perceived neighborhood stressors.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"25"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12031668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-01-29DOI: 10.1038/s44294-025-00054-2
Ola Gutzeit, Aakanksha Gulati, Zohreh Izadifar, Anna Stejskalova, Hassan Rhbiny, Justin Cotton, Bogdan Budnik, Sanjid Shahriar, Girija Goyal, Abidemi Junaid, Donald E Ingber
{"title":"Cervical mucus in linked human Cervix and Vagina Chips modulates vaginal dysbiosis.","authors":"Ola Gutzeit, Aakanksha Gulati, Zohreh Izadifar, Anna Stejskalova, Hassan Rhbiny, Justin Cotton, Bogdan Budnik, Sanjid Shahriar, Girija Goyal, Abidemi Junaid, Donald E Ingber","doi":"10.1038/s44294-025-00054-2","DOIUrl":"10.1038/s44294-025-00054-2","url":null,"abstract":"<p><p>This study explores the protective role of cervicovaginal mucus in maintaining vaginal health, particularly in relation to bacterial vaginosis (BV), using organ chip technology. By integrating human Cervix and Vagina Chips, we demonstrated that cervical mucus significantly reduces inflammation and epithelial damage caused by a dysbiotic microbiome commonly associated with BV. Proteomic analysis of the Vagina Chip, following exposure to mucus from the Cervix Chip, revealed differentially abundant proteins, suggesting potential biomarkers and therapeutic targets for BV management. Our findings highlight the essential function of cervical mucus in preserving vaginal health and underscore the value of organ chip models for studying complex interactions within the female reproductive tract. This research provides new insights into the mechanisms underlying vaginal dysbiosis and opens avenues for developing targeted therapies and diagnostic tools to enhance women's reproductive health.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11779628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143083092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-05-15DOI: 10.1038/s44294-025-00077-9
Philip Bediako-Kakari, Mariella Monyo, Shakir Atoyebi, Adeniyi Olagunju
{"title":"Comparative modelling of foetal exposure to maternal long-acting injectable versus oral daily antipsychotics.","authors":"Philip Bediako-Kakari, Mariella Monyo, Shakir Atoyebi, Adeniyi Olagunju","doi":"10.1038/s44294-025-00077-9","DOIUrl":"10.1038/s44294-025-00077-9","url":null,"abstract":"<p><p>This study employed physiologically based pharmacokinetic (PBPK) modelling to compare the extent of foetal exposure between oral and long-acting injectable (LAI) aripiprazole and olanzapine. Adult and pregnancy PBPK models were developed and validated with relevant clinical data. Relevant indices of foetal exposure during pregnancy were predicted from concentration-time data at steady-state dosing for both oral and LAI formulations. Foetal C<sub>max</sub> for aripiprazole was 59-78% higher with LAI than oral, and 68-181% higher with LAI olanzapine than the oral formulation. Predicted cord:maternal ratios (range) were 0.59-0.69 for oral aripiprazole and 0.61-0.66 for LAI aripiprazole, 0.34-0.64 for oral olanzapine and 0.89-0.96 for LAI olanzapine. Also, cumulative foetal exposure over 28 days from oral formulations were generally predicted to be lower compared with their therapeutic-equivalent LAI. As <i>in utero</i> foetal exposure to maternal drugs does not necessarily translate to risk, these data should be interpreted in a broader context that includes benefit-risk assessments.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144096783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
npj women's healthPub Date : 2025-01-01Epub Date: 2025-06-12DOI: 10.1038/s44294-025-00079-7
F Boscolo Sesillo, H Manoochehri, P Duran, E Zelus, K L Christman, M Alperin
{"title":"Effect of lactation on postpartum pelvic floor muscle regeneration in preclinical model.","authors":"F Boscolo Sesillo, H Manoochehri, P Duran, E Zelus, K L Christman, M Alperin","doi":"10.1038/s44294-025-00079-7","DOIUrl":"10.1038/s44294-025-00079-7","url":null,"abstract":"<p><p>Pelvic floor muscle (PFM) recovery following childbirth is essential for preserving pelvic floor function. Despite this, the impact of parturition and lactation on pelvic muscle stem cells (MuSCs), indispensable for skeletal muscle maintenance and regeneration, remains unknown. We determined that vaginal delivery does not cause mechanical injury of the rat PFMs, enabling us to uncouple the effects of lactation on muscle homeostasis from PFM regeneration following simulated birth injury (SBI). Tibialis anterior (TA) served as non-pelvic control. This novel study demonstrates that in the absence of birth injury, lactation blocks MuSC proliferation in PFM and TA, suggesting that postpartum systemic milieu affects MuSCs in pelvic and non-pelvic muscles. In contrast, SBI negated the inhibitory effect of lactation on MuSCs in PFM but not in TA, indicating that local signals released by the injured muscle overcome systemic inhibitory effects of lactation, which persist in muscles remote from the site of injury.</p>","PeriodicalId":520241,"journal":{"name":"npj women's health","volume":"3 1","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}